Targeting NLRP1-CCL8 axis in the leukaemic niche suppresses AML via inhibition of PI3K-AKT signalling. Li X, Zhou Q, Hao X, Cao C, et al. Br J Haematol 2025;207:789-801.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li X, Zhou Q, Hao X, Cao C, et al. Targeting NLRP1-CCL8 axis in the leukaemic niche suppresses AML via inhibition of PI3K-AKT signalling. Br J Haematol 2025;207:789-801.
PMID: 40685774